Literature DB >> 32581092

Interferon Alpha Induces Multiple Cellular Proteins That Coordinately Suppress Hepadnaviral Covalently Closed Circular DNA Transcription.

Junjun Cheng1, Qiong Zhao1, Yan Zhou2, Liudi Tang3, Muhammad Sheraz3, Jinhong Chang1, Ju-Tao Guo4.   

Abstract

Covalently closed circular DNA (cccDNA) of hepadnaviruses exists as an episomal minichromosome in the nucleus of an infected hepatocyte and serves as the template for the transcription of viral mRNAs. It had been demonstrated by others and us that interferon alpha (IFN-α) treatment of hepatocytes induced a prolonged suppression of human and duck hepatitis B virus cccDNA transcription, which is associated with the reduction of cccDNA-associated histone modifications specifying active transcription (H3K9ac or H3K27ac), but not the histone modifications marking constitutive (H3K9me3) or facultative (H3K27me3) heterochromatin formation. In our efforts to identify IFN-induced cellular proteins that mediate the suppression of cccDNA transcription by the cytokine, we found that downregulating the expression of signal transducer and activator of transcription 1 (STAT1), structural maintenance of chromosomes flexible hinge domain containing 1 (SMCHD1), or promyelocytic leukemia (PML) protein increased basal level of cccDNA transcription activity and partially attenuated IFN-α suppression of cccDNA transcription. In contrast, ectopic expression of STAT1, SMCHD1, or PML significantly reduced cccDNA transcription activity. SMCHD1 is a noncanonical SMC family protein and implicated in epigenetic silencing of gene expression. PML is a component of nuclear domain 10 (ND10) and is involved in suppressing the replication of many DNA viruses. Mechanistic analyses demonstrated that STAT1, SMCHD1, and PML were recruited to cccDNA minichromosomes and phenocopied the IFN-α-induced posttranslational modifications of cccDNA-associated histones. We thus conclude that STAT1, SMCHD1, and PML may partly mediate the suppressive effect of IFN-α on hepadnaviral cccDNA transcription.IMPORTANCE Pegylated IFN-α is the only therapeutic regimen that can induce a functional cure of chronic hepatitis B in a small, but significant, fraction of treated patients. Understanding the mechanisms underlying the antiviral functions of IFN-α in hepadnaviral infection may reveal molecular targets for development of novel antiviral agents to improve the therapeutic efficacy of IFN-α. By a loss-of-function genetic screening of individual IFN-stimulated genes (ISGs) on hepadnaviral mRNAs transcribed from cccDNA, we found that downregulating the expression of STAT1, SMCHD1, or PML significantly increased the level of viral RNAs without altering the level of cccDNA. Mechanistic analyses indicated that those cellular proteins are recruited to cccDNA minichromosomes and induce the posttranslational modifications of cccDNA-associated histones similar to those induced by IFN-α treatment. We have thus identified three IFN-α-induced cellular proteins that suppress cccDNA transcription and may partly mediate IFN-α silencing of hepadnaviral cccDNA transcription.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  cccDNA; hepatitis B virus; interferons; transcription

Mesh:

Substances:

Year:  2020        PMID: 32581092      PMCID: PMC7431811          DOI: 10.1128/JVI.00442-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  93 in total

Review 1.  Molecular virology of hepatitis B virus for clinicians.

Authors:  Timothy M Block; Haitao Guo; Ju-Tao Guo
Journal:  Clin Liver Dis       Date:  2007-11       Impact factor: 6.126

2.  Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus.

Authors:  D J Petcu; C E Aldrich; L Coates; J M Taylor; W S Mason
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

3.  Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor.

Authors:  Adrien Decorsière; Henrik Mueller; Pieter C van Breugel; Fabien Abdul; Laetitia Gerossier; Rudolf K Beran; Christine M Livingston; Congrong Niu; Simon P Fletcher; Olivier Hantz; Michel Strubin
Journal:  Nature       Date:  2016-03-17       Impact factor: 49.962

4.  Retroviral DNA methylation and epigenetic repression are mediated by the antiviral host protein Daxx.

Authors:  Natalia Shalginskikh; Andrey Poleshko; Anna Marie Skalka; Richard A Katz
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

5.  Benefits and risks of nucleoside analog therapy for hepatitis B.

Authors:  Jules L Dienstag
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

6.  Proximity to PML nuclear bodies regulates HIV-1 latency in CD4+ T cells.

Authors:  Marina Lusic; Bruna Marini; Hashim Ali; Bojana Lucic; Roberto Luzzati; Mauro Giacca
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

7.  Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism.

Authors:  Congrong Niu; Li Li; Stephane Daffis; Julie Lucifora; Marc Bonnin; Sarah Maadadi; Eduardo Salas; Ruth Chu; Hilario Ramos; Christine M Livingston; Rudolf K Beran; Abhishek V Garg; Scott Balsitis; David Durantel; Fabien Zoulim; William E Delaney; Simon P Fletcher
Journal:  J Hepatol       Date:  2017-12-13       Impact factor: 25.083

8.  Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients.

Authors:  B Rehermann; K M Chang; J McHutchinson; R Kokka; M Houghton; C M Rice; F V Chisari
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

9.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

10.  Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes.

Authors:  Fei Liu; Matthew Campagna; Yonghe Qi; Xuesen Zhao; Fang Guo; Chunxiao Xu; Sichen Li; Wenhui Li; Timothy M Block; Jinhong Chang; Ju-Tao Guo
Journal:  PLoS Pathog       Date:  2013-09-12       Impact factor: 6.823

View more
  5 in total

Review 1.  Novel therapeutic strategies for chronic hepatitis B.

Authors:  Sandra Phillips; Ravi Jagatia; Shilpa Chokshi
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

Review 2.  Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA.

Authors:  Claryssa Bianca; Elizabeth Sidhartha; Claudio Tiribelli; Korri Elvanita El-Khobar; Caecilia H C Sukowati
Journal:  World J Hepatol       Date:  2022-05-27

Review 3.  Intracellular interferon signalling pathways as potential regulators of covalently closed circular DNA in the treatment of chronic hepatitis B.

Authors:  Zhi Yi Goh; Ee Chee Ren; Hui Ling Ko
Journal:  World J Gastroenterol       Date:  2021-04-14       Impact factor: 5.742

4.  Methylation profile of hepatitis B virus is not influenced by interferon α in human liver cancer cells.

Authors:  In Young Moon; Jin-Wook Kim
Journal:  Mol Med Rep       Date:  2021-08-13       Impact factor: 2.952

5.  Characterization of Episomal Replication of Bovine Papillomavirus Type 1 DNA in Long-Term Virion-Infected Saccharomyces Cerevisiae Culture.

Authors:  Quanmei Tu; Weixu Feng; Zhuo Chen; Qijia Li; Yu Zhao; Jun Chen; Pengfei Jiang; Xiangyang Xue; Lifang Zhang; Kong-Nan Zhao
Journal:  Virol Sin       Date:  2021-08-30       Impact factor: 4.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.